Umashanker Navik

Bathinda, PB 151401, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 60 publications

Corrigendum to "Sinapic acid-pullulan based inflammation responsive nanomicelles for the local treatment of experimental inflammatory arthritis" [Int. J. Biol. Macromol. 278 (2024) 134903].

Corrigendum to "Sinapic acid-pullulan based inflammation responsive nanomicelles for the local treatment of experimental inflammatory arthritis" [Int. J. Biol. Macromol. 278 (2024) 134903].

Journal: International journal of biological macromolecules

Published: May 23, 2026

Betaine as a regulator of metabolism, epigenetics, and cellular osmoprotection: therapeutic implications in cardiometabolic and renal diseases.

Betaine as a regulator of metabolism, epigenetics, and cellular osmoprotection: therapeutic implications in cardiometabolic and renal diseases.

Journal: Frontiers in pharmacology

Published: May 17, 2026

Therapeutic potential of HDAC6 inhibitor Tubastatin A in health and diseases: current perspective and future directions.

Therapeutic potential of HDAC6 inhibitor Tubastatin A in health and diseases: current perspective and future directions.

Journal: Military Medical Research

Published: May 01, 2026

Doxorubicin-induced cardiotoxicity: Is ferroptosis the primary driver or a downstream amplifier?

Doxorubicin-induced cardiotoxicity: Is ferroptosis the primary driver or a downstream amplifier?

Journal: EXCLI journal

Published: April 28, 2026

Design and synthesis of N-3-substituted quinazolinone derivatives as anticancer agents targeting EGFR.

Design and synthesis of N-3-substituted quinazolinone derivatives as anticancer agents targeting EGFR.

Journal: RSC medicinal chemistry

Published: December 21, 2025

Visnagin Attenuates Thioacetamide-Induced Liver Injury and Fibrosis Through the Modulation of TLR4-Mediated Inflammation and Downregulation of TGF-β/α-SMA-Driven Fibrogenesis.

Visnagin Attenuates Thioacetamide-Induced Liver Injury and Fibrosis Through the Modulation of TLR4-Mediated Inflammation and Downregulation of TGF-β/α-SMA-Driven Fibrogenesis.

Journal: Journal of applied toxicology : JAT

Published: December 11, 2025

Network pharmacology-based therapeutic intervention of Mentha arvensis targeting cancer and doxorubicin-induced cardiotoxicity.

Network pharmacology-based therapeutic intervention of Mentha arvensis targeting cancer and doxorubicin-induced cardiotoxicity.

Journal: Investigational new drugs

Published: November 01, 2025

Design, Synthesis, and Anticancer Assessment of Benzylated Pyrrole-Based Pyrido[2,3-d]Pyrimidines as Thymidylate Synthase Inhibitors.

Design, Synthesis, and Anticancer Assessment of Benzylated Pyrrole-Based Pyrido[2,3-d]Pyrimidines as Thymidylate Synthase Inhibitors.

Journal: Chemical biology & drug design

Published: September 16, 2025

Hit-to‑lead optimization of new carbazoles as potential anticancer agents via targeting human topoisomerase II.

Hit-to‑lead optimization of new carbazoles as potential anticancer agents via targeting human topoisomerase II.

Journal: Bioorganic chemistry

Published: August 14, 2025

Sclareol mitigates steatosis, inflammation, and fibrosis through the regulation of AMPK/SREBP1/NF-κB/TGF-β pathways in metabolic dysfunction-associated steatohepatitis.

Sclareol mitigates steatosis, inflammation, and fibrosis through the regulation of AMPK/SREBP1/NF-κB/TGF-β pathways in metabolic dysfunction-associated steatohepatitis.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: June 06, 2025

Visnagin attenuates thioacetamide-induced kidney damage through suppression of renal injury marker, oxidative stress, inflammation, apoptosis, and TGF-β-mediated renal fibrosis.

Visnagin attenuates thioacetamide-induced kidney damage through suppression of renal injury marker, oxidative stress, inflammation, apoptosis, and TGF-β-mediated renal fibrosis.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: May 28, 2025

Calcium signalling and organelle crosstalk in cardiovascular disease: an interplay of cardiac cell death pathways.

Calcium signalling and organelle crosstalk in cardiovascular disease: an interplay of cardiac cell death pathways.

Journal: Molecular biology reports

Published: May 18, 2025

Showing 1-12 of 60

Last Updated: 09/26/2026